These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 27583583)

  • 1. Predictive Model for Estimating the Cost of Incident Diabetes Complications.
    Zhu J; Kahn P; Knudsen J; Mehta SN; Gabbay RA
    Diabetes Technol Ther; 2016 Oct; 18(10):625-634. PubMed ID: 27583583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative burden of diabetes complications on healthcare costs: The population-based CINECA-SID ARNO Diabetes Observatory.
    Pagano E; De Rosa M; Rossi E; Cinconze E; Marchesini G; Miccoli R; Vaccaro O; Bonora E; Bruno G
    Nutr Metab Cardiovasc Dis; 2016 Oct; 26(10):944-50. PubMed ID: 27289165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annual direct medical costs associated with diabetes-related complications in the event year and in subsequent years in Hong Kong.
    Jiao F; Wong CKH; Tang SCW; Fung CSC; Tan KCB; McGhee S; Gangwani R; Lam CLK
    Diabet Med; 2017 Sep; 34(9):1276-1283. PubMed ID: 28636749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct medical costs for complications among children and adults with diabetes in the US commercial payer setting.
    Yeaw J; Halinan S; Hines D; Delozier A; Perez M; Boye M; Boye KS; Blanchette CM
    Appl Health Econ Health Policy; 2014 Apr; 12(2):219-30. PubMed ID: 24573912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications.
    Zhuo X; Zhang P; Hoerger TJ
    Am J Prev Med; 2013 Sep; 45(3):253-61. PubMed ID: 23953350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating costs of diabetes complications in people <65 years in the U.S. using panel data.
    Yang W; Cintina I; Hoerger T; Neuwahl SJ; Shao H; Laxy M; Zhang P
    J Diabetes Complications; 2020 Dec; 34(12):107735. PubMed ID: 32962890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective.
    Viriato D; Calado F; Gruenberger JB; Ong SH; Carvalho D; Silva-Nunes J; Johal S; Viana R
    J Med Econ; 2014 Jul; 17(7):499-507. PubMed ID: 24708176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making.
    Palmer AJ; Roze S; Valentine WJ; Minshall ME; Foos V; Lurati FM; Lammert M; Spinas GA
    Curr Med Res Opin; 2004 Aug; 20 Suppl 1():S5-26. PubMed ID: 15324513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Different Strategies of Assessing the Economic Impact of Multiple Diabetes-Associated Complications and Their Interactions: A Large Claims-Based Study in Germany.
    Kähm K; Laxy M; Schneider U; Holle R
    Pharmacoeconomics; 2019 Jan; 37(1):63-74. PubMed ID: 30167918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a chronic disease management service for patients with diabetes on hospitalisation and acute care costs.
    Rasekaba TM; Lim WK; Hutchinson AF
    Aust Health Rev; 2012 May; 36(2):205-12. PubMed ID: 22624643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct medical costs of complications resulting from type 2 diabetes in the U.S.
    O'Brien JA; Shomphe LA; Kavanagh PL; Raggio G; Caro JJ
    Diabetes Care; 1998 Jul; 21(7):1122-8. PubMed ID: 9653606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012).
    Ward A; Alvarez P; Vo L; Martin S
    J Med Econ; 2014 Mar; 17(3):176-83. PubMed ID: 24410011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General population versus disease-specific event rate and cost estimates: potential bias for economic appraisals.
    Goeree R; O'Reilly D; Hopkins R; Blackhouse G; Tarride JE; Xie F; Lim M
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):379-84. PubMed ID: 20715915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the cost of complications of diabetes in Australia using administrative health-care data.
    Clarke P; Leal J; Kelman C; Smith M; Colagiuri S
    Value Health; 2008; 11(2):199-206. PubMed ID: 18380631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cost-effectiveness analysis of pioglitazone plus metformin compared with rosiglitazone plus metformin from a third-party payer perspective in the US.
    St Charles M; Minshall ME; Pandya BJ; Baran RW; Tunis SL
    Curr Med Res Opin; 2009 Jun; 25(6):1343-53. PubMed ID: 19419339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost of treating type 2 diabetes (CODEIRE).
    Nolan JJ; O'Halloran D; McKenna TJ; Firth R; Redmond S
    Ir Med J; 2006; 99(10):307-10. PubMed ID: 17274175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model-based economic evaluation of improved primary care management of patients with type 2 diabetes in Australia.
    Haji Ali Afzali H; Gray J; Beilby J; Holton C; Karnon J
    Appl Health Econ Health Policy; 2013 Dec; 11(6):661-70. PubMed ID: 24243516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.